Supply of Scopolamine Transdermal Patches

The contract involves the procurement and delivery of three Scopolamine Transdermal Patches, identified by NSN 6505014562380, to Fort Bragg, North Carolina, under FOB Destination terms, meaning the seller assumes responsibility for transport costs and risks until the goods arrive at the designated location. The delivery must comply with all applicable federal pharmaceutical handling standards to ensure product integrity, security, and regulatory adherence throughout the supply chain. The contract falls under NAICS code 424210, classifying it as a pharmaceutical and drug merchant wholesaler activity, and is administered by the Defense Logistics Agency on behalf of the Department of Defense. Issued as a subcontract with a posted date of July 14, 2026, this agreement is part of a larger procurement framework managed through the DLA’s procurement system and is identified by contract SPE2DX25D9900 with delivery order SPE2DP26F7517. The absence of solicitation or set-aside details suggests this may be a direct or streamlined acquisition under federal supply scheduling or existing contract vehicles. All units must be dispatched with proper documentation, labeling, and cold chain controls where required, and delivery must be confirmed upon receipt at the military installation to verify compliance with quality and quantity requirements.